Research and Markets: Ebola and Marburg Infections - Pipeline Insights 2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qq289p/ebola_and_marburg) has announced the addition of the "Ebola and Marburg Infections-Pipeline Insights, 2014" subscription to their offering.

This Ebola and Marburg Infections-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Ebola and Marburg Infections.

This report provides information on the therapeutic development based on the Ebola and Marburg Infections dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope

• The report provides a snapshot of the global therapeutic landscape of Ebola and Marburg Infections
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Ebola and Marburg Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Ebola and Marburg Infections and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

1. Ebola and Marburg Infections Overview
2. Ebola and Marburg Infections Pipeline Therapeutics
3. Ebola and Marburg Infections Therapeutics under Development by Companies
4. Ebola and Marburg Infections Late Stage Products (Filed and Phase III)
5. Comparative Analysis
6. Ebola and Marburg Infections Mid Clinical Stage Products (Phase II)
7. Comparative Analysis
8. Ebola and Marburg Infections Early Clinical Stage Products (Phase I and IND Filed)
9. Comparative Analysis
10. Ebola and Marburg Infections Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Ebola and Marburg Infections - Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Ebola and Marburg Infections - Discontinued Products
19. Ebola and Marburg Infections - Dormant Products
20. Companies Involved in Therapeutics Development for Ebola and Marburg Infections

For more information visit http://www.researchandmarkets.com/research/qq289p/ebola_and_marburg